| Literature DB >> 26948372 |
Raymond Vanholder1, Denis Fouque2, Griet Glorieux3, Gunnar H Heine4, Mehmet Kanbay5, Francesca Mallamaci6, Ziad A Massy7, Alberto Ortiz8, Patrick Rossignol9, Andrzej Wiecek10, Carmine Zoccali6, Gérard Michel London11.
Abstract
The clinical picture of the uraemic syndrome is a complex amalgam of accelerated ageing and organ dysfunction, which progress in parallel to chronic kidney disease. The uraemic syndrome is associated with cardiovascular disease, metabolic bone disease, inflammation, protein energy wasting, intestinal dysbiosis, anaemia, and neurological and endocrine dysfunction. In this Review, we summarise specific, modern management options for the uraemic syndrome in chronic kidney disease. Although large randomised controlled trials are scarce, based on data from randomised controlled trials and observational studies, as well as pathophysiological reasoning, a therapeutic algorithm can be developed for this complex and multifactorial condition, with interventions targeting several modifiable factors simultaneously.Entities:
Mesh:
Year: 2016 PMID: 26948372 DOI: 10.1016/S2213-8587(16)00033-4
Source DB: PubMed Journal: Lancet Diabetes Endocrinol ISSN: 2213-8587 Impact factor: 32.069